Vaxcell-Bio Therapeutics
Develops CAR-T and CAR-NK immunotherapies for solid tumors and canine lymphoma.
323990 | KO
Overview
Corporate Details
- ISIN(s):
- KR7323990002
- LEI:
- Country:
- South Korea
- Address:
- 전라남도 화순군 화순읍 산단길 12-55, 화순군
- Website:
- https://vaxcell-bio.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Vaxcell-Bio Therapeutics is a biotechnology company specializing in the research and development of anti-cancer immunotherapies. The company's core R&D is centered on its proprietary Natural Killer (NK) cell and Chimeric Antigen Receptor (CAR) technology platforms, developing advanced CAR-T and CAR-NK cell therapies. Its pipeline targets a range of malignancies, including liver cancer, pancreatic cancer, small cell lung cancer, and other solid tumors. A notable product, Vaxleukin-15, is an approved immunotherapy adjunct for canine lymphoma. The company actively secures intellectual property for its novel methods of manufacturing high-purity immune cells, positioning itself as a key developer in patient-specific cancer treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-18 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.9 KB | ||
| 2025-09-17 00:00 |
Regulatory News Service
투자판단관련주요경영사항 (박스루킨-15주 (Vaxleukin-15 inj) 품목허가 변경신청 승인)
|
Korean | 11.2 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.2 MB | ||
| 2025-07-28 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 7.9 KB | ||
| 2025-06-24 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 126.2 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.2 MB | ||
| 2025-04-15 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-04-08 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 17.0 KB | ||
| 2025-04-08 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 17.1 KB | ||
| 2025-04-08 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 19.1 KB | ||
| 2025-04-08 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 19.1 KB | ||
| 2025-04-08 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 20.2 KB | ||
| 2025-04-08 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 20.2 KB | ||
| 2025-04-02 00:00 |
Regulatory News Service
유형자산취득결정(자율공시)
|
Korean | 8.1 KB | ||
| 2025-03-28 00:00 |
M&A Activity
[기재정정]합병등종료보고서(합병)
|
Korean | 32.6 KB |
Automate Your Workflow. Get a real-time feed of all Vaxcell-Bio Therapeutics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Vaxcell-Bio Therapeutics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Vaxcell-Bio Therapeutics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
